Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
Conditions:   Adenocarcinoma of the Bladder;   Distal Urethral Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Squamous Cell Carcinoma of the Bladder;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder;   Urethral Cancer Associated With Invasive Bladder CancerInterventions:   Drug: ...
Source: ClinicalTrials.gov - June 2, 2005 Category: Research Source Type: clinical trials